Latest News about MDGL
Recent news which mentions MDGL
From Benzinga
The 3 Most Undervalued Biotech Stocks to Buy: November 2023
November 14, 2023
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
November 02, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 19, 2023
From Benzinga
2 Risky Stocks With Massive Potential
October 17, 2023
From Motley Fool
This fund shows that industry expertise can help you make a lot of money in the stock market
October 02, 2023
From MarketWatch
Nike, Carnival And 3 Stocks To Watch Heading Into Friday
September 29, 2023
From Benzinga
Nike, Carnival, Activision Blizzard, Madrigal Pharmaceuticals, Tesla: Why These 5 Stocks Are On Investors' Radars Today?
September 28, 2023
From Benzinga
Wall Street Thinks Madrigal Pharmaceuticals Could Climb 93%. Here's Why It Could Happen Soon.
September 27, 2023
Tickers
MDGL
From Motley Fool
Investors Eye CymaBay's AFFIRM Study As Regulatory Uncertainties Ease
September 21, 2023
From Benzinga
1 Beaten-Down Stock That Could Soar by 86%, According to Wall Street
September 20, 2023
Tickers
MDGL
From Motley Fool
The Latest Analyst Ratings for Madrigal Pharmaceuticals
September 11, 2023
Tickers
MDGL
From Benzinga
Smucker, FuelCell Energy, Granite Ridge Resources And Other Big Stocks Moving Lower On Monday
September 11, 2023
From Benzinga
The 3 Best Biotech Stocks to Buy Now: September 2023
September 04, 2023
From InvestorPlace
3 Biotech Stocks That Wall Street Analysts Can’t Get Enough Of
August 30, 2023
From InvestorPlace
The 3 Most Promising Pharma Stocks to Own Now
August 30, 2023
From InvestorPlace
From Motley Fool
Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It
August 23, 2023
From Motley Fool
From MarketWatch
Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?
August 02, 2023
From Motley Fool
Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says
June 28, 2023
From Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 27, 2023
From Benzinga
From MarketWatch
2 Growth Stocks That Doubled in 2023 and Could Shoot 55% to 87% Higher, According to Wall Street
May 30, 2023
From Motley Fool
From Benzinga
From Motley Fool
Why These 3 Nasdaq Stocks Buckled Today
May 16, 2023
From Motley Fool
Viking Therapeutics Outperforms Expectations: Analyst Increases Price Target Following Successful VK2809 Trial
May 16, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
